JOHN N KAPOOR

CIK 1033150 · President & CEO · last filed 2018-01-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$21.47M

Companies

5

Total Filings

45

Lifetime Open-Market Net

-$50.88M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AKORN INC (AKRX) Delisted Director 2,413,432 -$52.53M 24 2018-01-26
Insys Therapeutics, Inc. (INSY) Delisted President & CEO 42,479,792 $1.57M 9 2017-08-14
NEOPHARM INC (NEOL) Delisted Chairman of the Board 5,210,151 $84.1K 7 2008-08-26
INGN Director 3,354,995 $6.40 $21.47M $0 3 2008-06-13
OPTION CARE INC/DE (OPTN) Delisted Director 3,305,173 $9.60 $31.73M $0 1 2007-06-07

Recent Filings · Page 5 of 5

45 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2007-08-20 NEOPHARM INC (NEOL) Delisted Grant (A) +60,913 $0 EDGAR
2007-06-07 OPTION CARE INC/DE (OPTN) Delisted Grant (A) $0 EDGAR
2007-06-04 INGN Grant (A) +7,919 $8 EDGAR
2007-06-01 INGN Grant (A) +7,919 $8 EDGAR
2007-03-15 AKORN INC (AKRX) Delisted Other (J) −158,493 $0 EDGAR
Showing 4145 of 45
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.